title: Targeted therapy for squamous cell lung cancer.
abstract: Lung squamous cell carcinoma (SqCC) is the second most common subtype of non-small-cell lung cancer and leads to 40,000-50,000 deaths per year in the USA. Management of non-small-cell lung cancer has dramatically changed over the past decade with the introduction of targeted therapeutic agents for genotypically selected individuals with lung adenocarcinoma. These agents lead to improved outcomes, and it has now become the standard of care to perform routine molecular genotyping of lung adenocarcinomas. By contrast, progress in lung SqCC has been modest, and there has yet to be a successful demonstration of targeted therapy in this disease. Here, we review exciting work from ongoing genomic characterization and biomarker validation efforts that have nominated several likely therapeutic targets in lung SqCCs. These studies suggest that targeted therapies are likely to be successful in the treatment of lung SqCCs and should be further explored in both preclinical models and in clinical trials.
authors: Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA ; Cancer Program, Broad Institute, Cambridge, MA, USA.
authors: Rachel G
authors: RG
authors: Liao
authors: Hideo
authors: H
authors: Watanabe
authors: Matthew
authors: M
authors: Meyerson
authors: Peter S
authors: PS
authors: Hammerman
references: Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53
references: 18938156
references: Gastroenterology. 2008 Oct;135(4):1358-1368, 1368.e1-4
references: 18692501
references: PLoS Med. 2006 Oct;3(10):e420
references: 17020408
references: J Clin Invest. 2009 May;119(5):1216-29
references: 19381019
references: J Clin Oncol. 2010 Oct 20;28(30):4609-15
references: 20855820
references: Proc Am Thorac Soc. 2012 May;9(2):72-3
references: 22550248
references: Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13568-73
references: 18757741
references: N Engl J Med. 2004 May 20;350(21):2129-39
references: 15118073
references: N Engl J Med. 2010 Oct 28;363(18):1693-703
references: 20979469
references: Cancer Res. 2005 Sep 1;65(17):7591-5
references: 16140923
references: N Engl J Med. 2009 Sep 3;361(10):947-57
references: 19692680
references: N Engl J Med. 2005 Jul 14;353(2):123-32
references: 16014882
references: Sci Transl Med. 2012 May 30;4(136):136ra70
references: 22649091
references: N Engl J Med. 2012 Jun 28;366(26):2455-65
references: 22658128
references: Cancer Discov. 2011 Jun;1(1):78-89
references: 22328973
references: Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8713-7
references: 18552176
references: Mod Pathol. 2012 Nov;25(11):1473-80
references: 22684217
references: N Engl J Med. 2012 Jun 28;366(26):2443-54
references: 22658127
references: N Engl J Med. 2010 Jun 24;362(25):2380-8
references: 20573926
references: Antioxid Redox Signal. 2010 Dec 1;13(11):1627-37
references: 20446773
references: Cancer Res. 2002 Sep 15;62(18):5196-203
references: 12234984
references: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7817-22
references: 16672372
references: Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11
references: 15329413
references: N Engl J Med. 2006 Jun 15;354(24):2619-21
references: 16775247
references: Nat Genet. 1999 Sep;23(1):18-20
references: 10471491
references: J Clin Oncol. 2008 Jul 10;26(20):3351-7
references: 18612151
references: J Clin Oncol. 2010 Mar 10;28(8):1387-94
references: 20142592
references: Nat Genet. 2009 Nov;41(11):1238-42
references: 19801978
references: J Clin Oncol. 2008 May 20;26(15):2442-9
references: 18458038
references: Science. 2004 Jun 4;304(5676):1497-500
references: 15118125
references: Nature. 2007 Aug 2;448(7153):561-6
references: 17625570
references: J Thorac Oncol. 2010 Jun;5(6 Suppl 3):S207-13
references: 20502275
references: Nature. 2012 Sep 27;489(7417):519-25
references: 22960745
references: N Engl J Med. 2008 Sep 25;359(13):1367-80
references: 18815398
references: PLoS One. 2011;6(6):e20351
references: 21666749
references: PLoS Med. 2010 Jul 27;7(7):e1000315
references: 20668658
references: Clin Cancer Res. 2012 Feb 15;18(4):1167-76
references: 22228640
references: Clin Cancer Res. 2010 Jul 15;16(14):3743-53
references: 20534738
references: Sci Transl Med. 2010 Dec 15;2(62):62ra93
references: 21160078
references: J Clin Oncol. 2010 Jul 1;28(19):3167-75
references: 20516446
references: Oncogene. 2005 Dec 15;24(56):8259-67
references: 16091734
references: Lancet. 2009 May 2;373(9674):1525-31
references: 19410716